Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price

13.75 ▼ -1.25 (-8.33%)
Open: 14.30 Vol: 403.16K Day's range: 13.75 - 14.9799 Mar 26, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TNXP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 13.81▼ 13.86▼ 13.89▼ 15.03▼ 13.88▼
MA10 13.84▼ 13.96▼ 14.37▼ 14.69▼ 15.04▼
MA20 13.85▼ 14.51▼ 14.99▼ 14.27▼ 15.99▼
MA50 13.97▼ 15.20▼ 15.28▼ 15.48▼ 24.61▼
MA100 14.55▼ 15.26▼ 14.53▼ 16.25▼ 58.25▼
MA200 15.15▼ 14.47▼ 14.46▼ 24.84▼ 5,085.23▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ -0.049▼ -0.180▼ 0.139▲ 0.587▲
RSI 31.875▼ 23.185▼ 27.783▼ 43.869▼ 38.144▼
STOCH 14.744▼ 4.490▼ 0.950▼ 55.028     8.706▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -85.079▼ -90.116▼
CCI -168.199▼ -81.356     -98.337     -34.114     -58.362    
Latest Filters Detected On TNXP
RSI $TNXP RSI(14) Crossed Below 50 Set Alert
▼ MACD $TNXP MACD(12,26,9) Crossed Below Zero Set Alert
MA $TNXP Price Crossed Below MA(26) Set Alert
MA $TNXP Price Crossed Below MA(13) Set Alert
▼ GAP $TNXP Open Gap Down %3 Set Alert
▼ GAP $TNXP Open Gap Down %2 Set Alert
Tonix Pharmaceuticals Holding Corp News
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Monday, March 23, 2026 02:41 PM
Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease ...
TNXP: ~2500 patients have initiated treatment with Tonmya following November 2025 commercial launch
Monday, March 23, 2026 08:33 AM
By David Bautz, PhD NASDAQ: TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Encouraging Initial Data from Tonmya™ Launch Following the approval of Tonmya™ (cyclobenzaprine HCl sublingual ...
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
Wednesday, March 18, 2026 02:20 PM
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology company, announced today that Seth Lederman, MD, Chief Executive Officer, ...
TNXP historical stock data
date open high low close volume
26/03/26 14.30 14.9799 13.75 13.75 403,163
25/03/26 15.50 15.915 14.97 15.00 333,915
24/03/26 15.84 16.35 15.20 15.34 418,146
23/03/26 15.10 16.1898 15.10 16.08 557,653
20/03/26 15.74 17.00 14.99 15.00 1,028,842
19/03/26 14.97 16.14 14.93 15.77 915,989
18/03/26 14.86 15.10 14.15 14.19 327,400
17/03/26 13.63 15.12 13.61 14.96 465,500
16/03/26 13.45 13.615 13.18 13.56 295,795
13/03/26 13.67 14.35 13.23 13.24 422,100
Quote Details
52wk Low:13.07
52wk High:69.97
Vol:403.16K
Avg Vol(3m):7.5M
1Y Chng:-20.52%
1M Chng:-9.00%
Add to Watch List
More Information
Index US Composite
Market Cap. 201.08M